The sBLA seeks approval for Eylea HD for both the treatment of macular edema following retinal vein occlusion and broadening the dosing schedule to include every-4-week dosing across approved indications.
Updated guidelines characterize IOLs by functional performance over optical design.
Ophthalmology Times – ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
Dysregulated lipid metabolism likely contributes to the pathogenesis of age-related macular degeneration (AMD). There is an overlap in risk factors between AMD and diseases of…
Steven R. Sarkisian Jr., MD, joins I. Paul Singh, MD, on Innovation Journal Club to discuss the impact of procedural pharmaceuticals on glaucoma management. Along…
I grew up in a conservative home. Not at all like what the word means today. We conserved.Dad grew a large vegetable garden from seeds,…
Leos is supported by emerging data from a randomized controlled clinical trial, further validating its safety and efficacy.
What does the literature tell us about the overall efficacy of teleretinal screening for DR and DME? And even if it is effective, how can…
To explore the safety and efficacy of the allogeneic induced pluripotent stem cell (iPSC)–derived retinal pigment epithelium (RPE) strip transplantation for patients with RPE degeneration.
➤ Positive results in Phase 1 trial for geographic atrophy cell-based therapy ➤ Enrollment complete for Phase 3 DME drop trials ➤ Enrollment complete in…
